This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of chiral intermediates for drug candidates. Its structure, featuring a trifluoromethyl group and an amino alcohol moiety, makes it valuable for designing molecules with specific biological activities. It is often employed in the creation of compounds targeting neurological disorders, such as antidepressants or antipsychotics, due to its potential interaction with neurotransmitter systems. Additionally, its chiral nature allows for the development of enantiomerically pure drugs, enhancing efficacy and reducing side effects. Researchers also explore its use in organic synthesis as a building block for complex molecules, leveraging its unique chemical properties for selective reactions.